Exploitation of the Results

The refined list of 'hits' will need to be synthesised and tested.

To make this possible a small company, Inhibox Ltd., has been set up to handle the exploitation of the results. The company will be owned by the National Foundation for Cancer Research and the University of Oxford, together with the commercial partner who will provide the requisite funding.

The scientists involved in the project do not have any ownership of the company, and any profits which would accrue to the NFCR or the University will of course be used to support further research into finding drugs to combat cancer.

More info at www.inhibox.com